As an increasing number of pharmaceutical companies experiment with different ways to cut costs and boost productivity amid the pandemic, the industry is increasingly switching to cloud-based technologies. In this scenario, Veeva has emerged as indispensable for the life sciences industry, helping life sciences enterprises manage customer databases, track drug developments, and organize clinical trials.
Veeva’s expansion in the industry, as well as newer industries such as consumer goods, has resulted in the next wave of growth in corresponding IT services. Veeva-specific IT services is estimated to be a US$2 billion opportunity by 2025, and service providers are building strong Veeva-specific solutions to expedite clients’ time-to-market.
In this report, we analyze 15 IT service providers’ Veeva services capabilities. These service providers are classified as Leaders, Major Contenders, and Aspirants based on their positioning on the Everest Group PEAK Matrix® – a composite index of distinct metrics related to a provider’s capability and market impact.
Scope
Industry: life sciences and pharmaceutical
Geography: global
Contents
This report provides:
An assessment of Veeva service providers on several capability and market success-related dimensions
A detailed profile of each service provider, including capability overview, case studies, recent developments, and enterprise sourcing considerations
The pandemic highlighted the need for increased virtual and digital interactions between life sciences enterprises and customers. Enterprises realized that life sciences-specific Customer Relationship Management (CRM) systems were not inherently equi…
